Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Buy
54
SSMXY Quote, Financials, Valuation and Earnings
Last price:
$18.65
Seasonality move
:
5.17%
Day range:
$18.63 - $18.69
52-week range:
$14.38 - $22.00
Dividend yield:
1.01%
P/E ratio:
33.33x
P/S ratio:
3.63x
P/B ratio:
3.77x
Volume:
67.3K
Avg. volume:
69.8K
1-year change:
2.4%
Market cap:
$11.6B
Revenue:
$3.2B
EPS (TTM):
$0.56
Analysts' Opinion
-
Consensus RatingSysmex has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Sysmex has an estimated downside of -- from its current price of $18.65.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $18.65.
Fair Value
-
According to the consensus of 0 analysts, Sysmex has -- downside to fair value with a price target of -- per share.
SSMXY vs. S&P 500
-
Over the past 5 trading days, Sysmex has underperformed the S&P 500 by -5.7% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sysmex does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sysmex has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Sysmex reported revenues of $718.1M.
Earnings Growth
-
Sysmex has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Sysmex reported earnings per share of $0.11.
Enterprise value:
11.2B
EV / Invested capital:
--
Price / LTM sales:
3.63x
EV / EBIT:
20.58x
EV / Revenue:
3.49x
PEG ratio (5yr expected):
8.41x
EV / Free cash flow:
117.89x
Price / Operating cash flow:
99.01x
Enterprise value / EBITDA:
14.10x
Gross Profit (TTM):
$1.7B
Return On Assets:
9.01%
Net Income Margin (TTM):
10.9%
Return On Equity:
12%
Return On Invested Capital:
11.96%
Operating Margin:
14.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $3.2B | $3.1B | $3.2B | $694.9M | $718.1M | |
| Gross Profit | $1.6B | $1.6B | $1.7B | $367.4M | $385.1M | |
| Operating Income | $550.1M | $571.4M | $565.5M | $96.8M | $107.4M | |
| EBITDA | $792.3M | $752.9M | $794.6M | $159.8M | $175.5M | |
| Diluted EPS | $0.58 | $0.54 | $0.56 | $0.10 | $0.11 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $2.2B | $2B | $2.1B | $2.4B | |
| Total Assets | $3.6B | $4B | $3.5B | $3.7B | $4.3B | |
| Current Liabilities | $648.6M | $796.5M | $675.1M | $693.4M | $752M | |
| Total Liabilities | $897.4M | $1.1B | $905.7M | $921.8M | $1.2B | |
| Total Equity | $2.7B | $2.9B | $2.6B | $2.8B | $3.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $523.2M | $509.8M | $442.9M | $226.9M | $179.6M | |
| Cash From Investing | -$312.2M | -$383.2M | -$380.9M | -$110.1M | -$97.4M | |
| Cash From Financing | -$183M | -$179.5M | -$62.5M | -$21M | $10.1M | |
| Free Cash Flow | $237.9M | $195M | $95M | $120.3M | $80.9M | |
SSMXY
Sector
Market Cap
$11.6B
$46.1M
Price % of 52-Week High
84.77%
46.02%
Dividend Yield
1.01%
0%
Shareholder Yield
1.92%
-0.6%
1-Year Price Total Return
2.4%
-30.52%
Beta (5-Year)
0.860
0.772
Dividend yield:
1.01%
Annualized payout:
$0.18
Payout ratio:
16.51%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$18.83
200-day SMA
Buy
Level
$17.94
Bollinger Bands (100)
Sell
Level
18.33 - 20.25
Chaikin Money Flow
Buy
Level
6.4M
20-day SMA
Sell
Level
$19.98
Relative Strength Index (RSI14)
Sell
Level
34.36
ADX Line
Sell
Level
14.48
Williams %R
Neutral
Level
-76.7857
50-day SMA
Sell
Level
$19.56
MACD (12, 26)
Sell
Level
-0.37
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
6.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.7311)
Buy
CA Score
(Annual)
Level (1.4232)
Buy
Beneish M-Score
(Annual)
Level (-2.5568)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.9499)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.
Stock Forecast FAQ
In the current month, SSMXY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SSMXY average analyst price target in the past 3 months is --.
-
Where Will Sysmex Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sysmex share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sysmex?
Analysts are divided on their view about Sysmex share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sysmex is a Sell and believe this share price will rise from its current level to --.
-
What Is Sysmex's Price Target?
The price target for Sysmex over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SSMXY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sysmex is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SSMXY?
You can purchase shares of Sysmex via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sysmex shares.
-
What Is The Sysmex Share Price Today?
Sysmex was last trading at $18.65 per share. This represents the most recent stock quote for Sysmex. Yesterday, Sysmex closed at $18.65 per share.
-
How To Buy Sysmex Stock Online?
In order to purchase Sysmex stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
